Our in silico analysis revealed that CDK12 defective PCa tumors that express higher levels of MHC are characterized by immunomodulator pathway expression such as IFN-γ-response and cytotoxic activity genes. The gene discussed is CDK12; the disease is posterior cortical atrophy.